Discovery and Development of a Potent and Highly Selective Small Molecule Muscarinic Acetylcholine Receptor Subtype I (mAChR 1 or M1) Antagonist In Vitro and In Vivo Probe

Author(s): C. David Weaver , Douglas J. Sheffler , L. Michelle Lewis , Thomas M. Bridges , Richard Williams , Natalia T. Nalywajko , J. Phillip Kennedy , Matthew M. Mulder , Satyawan Jadhav , Leslie A. Aldrich , Carrie K. Jones , Joy Marlo , Colleen M. Niswender , Matthew M. Mock , Fang Zheng , P. Jeffrey Conn , Craig W. Lindsley .

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 13 , 2009

Become EABM
Become Reviewer

Abstract:

This article describes the discovery and development of the first highly selective, small molecule antagonist of the muscarinic acetylcholine receptor subtype I (mAChR1 or M1). An M1 functional, cell-based, calcium-mobilization assay identified three distinct chemical series with initial selectivity for M1 versus M4. An iterative parallel synthesis approach was employed to optimize all three series in parallel, which led to the development of novel microwave-assisted chemistry and provided important take home lessons for probe development projects. Ultimately, this effort produced VU0255035, a potent (IC50 = 130 nM) and selective ( > 75-fold vs. M2-M5 and > 10 iM vs. a panel of 75 GPCRs, ion channels and transporters) small molecule M1 antagonist. Further profiling demonstrated that VU0255035 was centrally penetrant (BrainAUC/PlasmaAUC of 0.48) and active in vivo, rendering it acceptable as both an in vitro and in vivo MLSCN/ MLPCN probe molecule for studying and dissecting M1 function.

Keywords: Muscarinic, acetylcholine, mAChR, M1, antagonist

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 13
Year: 2009
Page: [1217 - 1226]
Pages: 10
DOI: 10.2174/156802609789753635
Price: $58

Article Metrics

PDF: 12